Korea Review/Outlook: Biopharma Support Policies, Regulatory Innovation In The Spotlight
Long-Awaited 'Control Tower' Kicks Off
Steps to foster the biopharma industry, a regulatory science innovation law and a new pan-government policy control tower were among the highlights of policy and regulatory activity in South Korea in 2023 set to have an ongoing impact throughout this year.
